All Stories

  1. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2019, Dove Medical Press

    Roy Pleasants

  2. Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease

    Article • Annals of Pharmacotherapy, September 2018, SAGE Publications

    Roy Pleasants

  3. Assessing the impact of a remote digital coaching engagement program on patient-reported outcomes in asthma

    Article • Journal of Asthma, August 2017, Taylor & Francis

    Roy Pleasants, cindy green

  4. Defining and targeting health disparities in chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2016, Dove Medical Press

    Roy Pleasants

  5. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2015, Dove Medical Press

    Roy Pleasants

  6. Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2015, Taylor & Francis

    Roy Pleasants